Suffering on such an immense scale can appear hopeless. However, a technique called CRISPR gene editing promises to help deal with these issues and many more—and wise regulation can spur it on.

Legislatures, governors, government agencies, and plaintiff attorneys are taking action against ultra-processed foods, but there is no clear definition of ultra-processed foods and there is little ...

And it is at this intersection that the future of medicine is being written, with innovations like CRISPR and CAR-T therapy unlocking the potential to not only treat diseases but cure them.

1 At conferences like Pittcon, where analytical chemistry and life science collide, CRISPR’s growing influence is unmistakable, taking a prominent place in the Bioanalytical & Life Sciences and ...

A proof-of-concept study shows that CRISPR-Cas9 can eliminate extra chromosome copies in Down syndrome cells. The method restores normal gene function but is not yet ready for human trials. Scientists ...

Spot­light Ther­a­peu­tics, a start­up with a bold vi­sion for de­liv­er­ing CRISPR ther­a­pies in­to the body with­out the need for vi­ral vec­tors or lipid nanopar­ti­cles, has … ...

CRISPR Gene-Edited Plants May Fall Outside ... DNA is not subject to regulation by APHIS under 7 CFR Part 340. The definition of “regulated article” may leave a regulatory gap for GE plants ...

Crispr Therapeutics AG reported significant revenue declines in Q4 and FY24 due to reduced collaboration revenues, but maintains strong financial health with $298m cash and $1.6bn in marketable ...

Using CRISPR-Cas9 targeting multiple cancer-specific mutations, we developed an innovative approach called cancer-specific insertions and deletions attacker that can induce targeted cancer cell death ...

CRISPR, or Clustered Regularly Interspaced Short Palindromic Repeats, is an advanced technology developed in 2012 that can be used to edit genes. It can be used to find specific DNA sequences ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

CRISPR-Cas9 (clustered regularly interspaced short palindromic repeat and associated Cas9 protein) is a molecular tool with transformative genome editing capabilities. At the molecular level, an ...